Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

A New Look into the Mode of Action of Metal-Based Anticancer Drugs.

Marques MPM, Batista de Carvalho ALM, Mamede AP, Dopplapudi A, Rudić S, Tyagi M, Garcia Sakai V, Batista de Carvalho LAE.

Molecules. 2020 Jan 7;25(2). pii: E246. doi: 10.3390/molecules25020246.

2.

Multi-Organ NMR Metabolomics to Assess In Vivo Overall Metabolic Impact of Cisplatin in Mice.

Carneiro TJ, Araújo R, Vojtek M, Gonçalves-Monteiro S, Diniz C, Batista de Carvalho ALM, Marques MPM, Gil AM.

Metabolites. 2019 Nov 13;9(11). pii: E279. doi: 10.3390/metabo9110279.

3.

Chemotherapeutic Targets in Osteosarcoma: Insights from Synchrotron-MicroFTIR and Quasi-Elastic Neutron Scattering.

Marques MPM, Batista de Carvalho ALM, Mamede AP, Santos IP, García Sakai V, Dopplapudi A, Cinque G, Wolna M, Gardner P, Batista de Carvalho LAE.

J Phys Chem B. 2019 Aug 15;123(32):6968-6979. doi: 10.1021/acs.jpcb.9b05596. Epub 2019 Aug 6.

PMID:
31339317
4.

Anticancer drug impact on DNA - a study by neutron spectroscopy coupled with synchrotron-based FTIR and EXAFS.

Batista de Carvalho ALM, Mamede AP, Dopplapudi A, Garcia Sakai V, Doherty J, Frogley M, Cinque G, Gardner P, Gianolio D, Batista de Carvalho LAE, Marques MPM.

Phys Chem Chem Phys. 2019 Feb 20;21(8):4162-4175. doi: 10.1039/c8cp05881d.

PMID:
30656331
5.

Bioinspired-Metalloporphyrin Magnetic Nanocomposite as a Reusable Catalyst for Synthesis of Diastereomeric (-)-Isopulegol Epoxide: Anticancer Activity Against Human Osteosarcoma Cells (MG-63).

Dias LD, Batista de Carvalho ALM, Pinto SMA, Aquino GLB, Calvete MJF, Rossi LM, Marques MPM, Pereira MM.

Molecules. 2018 Dec 24;24(1). pii: E52. doi: 10.3390/molecules24010052.

6.

Anti-Invasive and Anti-Proliferative Synergism between Docetaxel and a Polynuclear Pd-Spermine Agent.

Batista de Carvalho AL, Medeiros PS, Costa FM, Ribeiro VP, Sousa JB, Diniz C, Marques MP.

PLoS One. 2016 Nov 23;11(11):e0167218. doi: 10.1371/journal.pone.0167218. eCollection 2016.

Supplemental Content

Loading ...
Support Center